No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.
暂无分享,去创建一个
[1] S. Sarin,et al. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[2] H. El‐Serag,et al. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] M. Spite,et al. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. , 2012, Annual review of nutrition.
[4] J. Heimbach,et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.
[5] B. Neuschwander‐Tetri,et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease , 2010, Hepatology.
[6] A. Sanyal,et al. Population-based risk factors and resource utilization for HCC: US perspective , 2010, Current medical research and opinion.
[7] R. Rodrigo,et al. Decreased Liver Fatty Acid Δ‐6 and Δ‐5 Desaturase Activity in Obese Patients , 2010, Obesity.
[8] B. Neuschwander‐Tetri,et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.
[9] M. Garg,et al. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-Redefining platelet response to fish oils. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.
[10] Chunhong Bai,et al. Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] A. Feldstein,et al. Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis , 2008, The American Journal of Gastroenterology.
[12] T. Aoyama,et al. Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis , 2008, Journal of clinical gastroenterology.
[13] G. Schmitz,et al. The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.
[14] Michelle M Wiest,et al. A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.
[15] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[16] G. Bedogni,et al. Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study , 2006, Alimentary pharmacology & therapeutics.
[17] Robert A Fisher,et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.
[18] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[19] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[20] B. Zauscher,et al. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. , 2005, Transplantation.
[21] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[22] L. Burgart,et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial , 2004, Hepatology.
[23] R. Karim,et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.
[24] S. Clarke. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[25] T. Kurabayashi,et al. Eicosapentaenoic Acid Effect on Hyperlipidemia in Menopausal Japanese Women , 2000, Obstetrics and gynecology.
[26] G. Marchesini,et al. Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.
[27] N. Kalupahana,et al. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. , 2012, Advances in food and nutrition research.
[28] J. Maher. Alcoholic steatosis and steatohepatitis. , 2002, Seminars in gastrointestinal disease.
[29] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.